Revenue Growth Reinforces Twist Bioscience Corp.’s (TWST) Technology Leadership
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Posts Tagged ‘NASDAQ:TWST’
Twist Bioscience (TWST) Surged on Strong Results and AI Drug Discovery Demand
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for its "Artisan Small Cap Fund".
10 Best Performing American Stocks in June 2026
June’s biggest American stock winners came during a market where investors were highly rewarding companies tied to earnings growth, AI infrastructure, cyclicals, and sector-...
Investor’s Favored Twist Bioscience’s (TWST) Association with Technology Companies
Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its “Osterweis Opportunity Fund”.
Is Twist Bioscience Corporation (TWST) a Strong Buy After Guggenheim Lifts Price Target?
TheFly reported on May 5 that a Guggenheim analyst increased the price target on TWST from $55 to $60 while maintaining a Buy rating on the stock.
8 Best Immunology Stocks to Buy According to Hedge Funds
Despite growing geopolitical tensions related to the Iran war, Callanish Capital CEO Haig Bathgate shared an optimistic stance on global markets during an appearance on CNCB on...
10 Best ARK Stocks to Buy Right Now
On January 15, Cathie Wood, in her Outlook for 2026, said that the US economy has formed a "coiled spring," referencing ARK Investment Management analysis.
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
Twist Bioscience Corporation (NASDAQ:TWST) is one of the best performing healthcare stocks so far in 2026.
10 Best Performing Healthcare Stocks So Far in 2026
She was of the view that the backdrop at present is featuring geopolitical tensions, Fed policy uncertainty, inflation concerns, and still, it is incredible that the stock market...
Twist Bioscience Corp (TWST) Climbed on Earnings Beat
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download...
Twist Bioscience Corp. (TWST) Rallied on Record-Breaking Quarterly Report
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2026 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2026 Earnings Call Transcript May 4, 2026Twist Bioscience Corporation misses on earnings expectations.
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026Twist Bioscience Corporation misses on earnings expectations.
Twist Bioscience Corporation (TWST): A Bull Case Theory
We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will summarize the bulls’ thesis on TWST.
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)
TheFly reported on December 15, 2025, that Barclays kept its Overweight rating and boosted its price objective for Twist Bioscience Corporation (NASDAQ:TWST) from $37 to $39.
12 Best Genomics Stocks to Invest In
Companies that study DNA to improve people's lives are known as genomics stocks.
7 Most Promising Gene Editing Stocks According to Analysts
Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, delete, or modify DNA within living cells.
Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT
Twist Bioscience Corporation (NASDAQ:TWST) is one of the best gene-editing stocks to buy according to hedge funds.
9 Best Gene-Editing Stocks to Buy According to Hedge Funds
Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.
Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2025 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2025 Earnings Call Transcript November 14, 2025Twist Bioscience Corporation beats earnings expectations.
Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3
Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
TD Cowen Reaffirms Buy on Twist Bioscience (TWST) Amid Scaling and Margin Gains
Twist Bioscience Corp. (NASDAQ:TWST) is one of the best emerging technology stocks to buy right now.
11 Best Emerging Technology Stocks to Buy Right Now
While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence began rewriting them.
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2025 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2025 Earnings Call Transcript August 4, 2025Twist Bioscience Corporation beats earnings expectations.
Is Twist Bioscience Corp. (TWST) Nearing Profitability?
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions
Twist Bioscience Corporation (NASDAQ:TWST) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential
Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, a San Francisco-based venture capital firm established in 2013.
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript May 5, 2025Twist Bioscience Corporation misses on earnings expectations.
10 Worst High-Risk High-Reward Growth Stocks To Buy
On March 14, Tom Lee managing partner and head of research at Fundstrat Global Advisors appeared on a CNBC interview to talk about how the markets react to crises and what approach...
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
Cathie Wood’s Stock Portfolio: 2025 Stock Picks
Cathie Wood is one of Wall Street's most contentious figures.
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2025 Earnings Call Transcript
Operator: Good day. Thank you for standing by. Welcome to Twist Bioscience's 2025 First Quarter Financial Results Conference Call.
10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2024 Earnings Call Transcript
Operator: Welcome to Twist Bioscience's 2024 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors.
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2024 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2024 Earnings Call Transcript August 2, 2024Twist Bioscience Corporation misses on earnings expectations.
Is Twist Bioscience Corporation (TWST) in the Pole Position?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood
As the saying goes, time and tide wait for nobody.
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript
Operator: Welcome to Twist Bioscience's Fiscal 2024 Second Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode.
5 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 5 fastest growing health tech companies in the world.
5 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 5 fastest growing biotech companies in the US.
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2024 Earnings Call Transcript
Operator: Welcome to Twist Bioscience's Fiscal 2024 First Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode.
15 Stocks That Will Outperform the S&P 500 in 2024
In this article, we will take a detailed look at the 15 Stocks That Will Outperform the S&P 500 in 2024. For a quick overview of such stocks, read our article 5 Stocks That...
Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript
Operator: Welcome to the Twist Bioscience’s Fiscal 2023 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood’s Portfolio
In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.
Should You Add Twist Bioscience Corporation (TWST) to Your Portfolio?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Twist Bioscience’s Fiscal 2023 Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center
